Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-29

Clinical Trial Update: Infliximab (Remicade) for Patients With Acute Kawasaki Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating infliximab (Remicade) for acute Kawasaki disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: University of California, San Diego | Conditions: Kawasaki Disease | Phase 1 | Status: COMPLETED | Results posted: 2009-12-29